Eintrag weiter verarbeiten
Similarities and differences in the clinical features between cardia varices and esophageal varices
Gespeichert in:
Zeitschriftentitel: | Journal of Gastroenterology and Hepatology |
---|---|
Personen und Körperschaften: | , , , , , , , , , |
In: | Journal of Gastroenterology and Hepatology, 29, 2014, 11, S. 1911-1918 |
Medientyp: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
Wiley
|
Schlagwörter: |
author_facet |
Kondo, Takayuki Maruyama, Hitoshi Kiyono, Soichiro Sekimoto, Tadashi Shimada, Taro Takahashi, Masanori Okugawa, Hidehiro Kobayashi, Satoshi Yoshizumi, Hiroaki Yokosuka, Osamu Kondo, Takayuki Maruyama, Hitoshi Kiyono, Soichiro Sekimoto, Tadashi Shimada, Taro Takahashi, Masanori Okugawa, Hidehiro Kobayashi, Satoshi Yoshizumi, Hiroaki Yokosuka, Osamu |
---|---|
author |
Kondo, Takayuki Maruyama, Hitoshi Kiyono, Soichiro Sekimoto, Tadashi Shimada, Taro Takahashi, Masanori Okugawa, Hidehiro Kobayashi, Satoshi Yoshizumi, Hiroaki Yokosuka, Osamu |
spellingShingle |
Kondo, Takayuki Maruyama, Hitoshi Kiyono, Soichiro Sekimoto, Tadashi Shimada, Taro Takahashi, Masanori Okugawa, Hidehiro Kobayashi, Satoshi Yoshizumi, Hiroaki Yokosuka, Osamu Journal of Gastroenterology and Hepatology Similarities and differences in the clinical features between cardia varices and esophageal varices Gastroenterology Hepatology |
author_sort |
kondo, takayuki |
spelling |
Kondo, Takayuki Maruyama, Hitoshi Kiyono, Soichiro Sekimoto, Tadashi Shimada, Taro Takahashi, Masanori Okugawa, Hidehiro Kobayashi, Satoshi Yoshizumi, Hiroaki Yokosuka, Osamu 0815-9319 1440-1746 Wiley Gastroenterology Hepatology http://dx.doi.org/10.1111/jgh.12647 <jats:title>Abstract</jats:title><jats:sec><jats:title>Background and Aim</jats:title><jats:p>Little is known about the clinical features of cardia varices (<jats:styled-content style="fixed-case">CV</jats:styled-content>). The aim was to examine the background, bleeding risk, and post‐treatment outcomes of <jats:styled-content style="fixed-case">CV</jats:styled-content> in patients with portal hypertension.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>The subjects of this retrospective study were 277 patients (179 males, 98 females, 62.9 ± 11.5 years) with esophageal varices (<jats:styled-content style="fixed-case">EV</jats:styled-content>). In patients with CV, there were 65 bleeders, and 95 patients received endoscopic treatment for primary or secondary prophylaxis.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>There were 147 patients with <jats:styled-content style="fixed-case">CV</jats:styled-content> (53.1%). The higher grade of <jats:styled-content style="fixed-case">EV</jats:styled-content> (<jats:italic>P</jats:italic> < 0.01) and the lower grade of gastric fundal varices (<jats:styled-content style="fixed-case">FV</jats:styled-content>) (<jats:italic>P</jats:italic> = 0.046) were significant factors for the presence of <jats:styled-content style="fixed-case">CV</jats:styled-content>. Significant risk factors for bleeding were: the higher grade of <jats:styled-content style="fixed-case">EV</jats:styled-content> (<jats:italic>P</jats:italic> < 0.01), red sign on <jats:styled-content style="fixed-case">EV</jats:styled-content> (<jats:italic>P</jats:italic> < 0.01), lower albumin (<jats:italic>P</jats:italic> = 0.01), and <jats:styled-content style="fixed-case">C</jats:styled-content>hild‐<jats:styled-content style="fixed-case">P</jats:styled-content>ugh B/C (<jats:italic>P</jats:italic> < 0.01) for <jats:styled-content style="fixed-case">EV</jats:styled-content> and red sign on <jats:styled-content style="fixed-case">CV</jats:styled-content> (<jats:italic>P</jats:italic> < 0.01) and use of non‐steroidal anti‐inflammatory drugs (<jats:styled-content style="fixed-case">NSAID</jats:styled-content>s)/aspirin (<jats:italic>P</jats:italic> < 0.01) for <jats:styled-content style="fixed-case">CV</jats:styled-content>. All <jats:styled-content style="fixed-case">CV</jats:styled-content> disappeared by sclerotherapy combined with argon plasma coagulation or band ligation, and 20 patients (21.1%) in EV and 18 patients (18.9%) in CV had recurrences during the median observation period of 19.4 months. There was no significant difference in the cumulative survival rate between non‐bleeders, bleeders from <jats:styled-content style="fixed-case">EV</jats:styled-content>, and those from <jats:styled-content style="fixed-case">CV</jats:styled-content>.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>The <jats:styled-content style="fixed-case">CV</jats:styled-content> were closely associated with advanced grade of <jats:styled-content style="fixed-case">EV</jats:styled-content> and less‐advanced grade of <jats:styled-content style="fixed-case">FV</jats:styled-content>. Further, usage of <jats:styled-content style="fixed-case">NSAIDs</jats:styled-content>/aspirin and red sign were significantly related to the bleeding from <jats:styled-content style="fixed-case">CV</jats:styled-content>, suggesting the need for careful management.</jats:p></jats:sec> Similarities and differences in the clinical features between cardia varices and esophageal varices Journal of Gastroenterology and Hepatology |
doi_str_mv |
10.1111/jgh.12647 |
facet_avail |
Online |
finc_class_facet |
Medizin |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qZ2guMTI2NDc |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qZ2guMTI2NDc |
institution |
DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-D161 DE-Gla1 DE-Zi4 DE-15 |
imprint |
Wiley, 2014 |
imprint_str_mv |
Wiley, 2014 |
issn |
0815-9319 1440-1746 |
issn_str_mv |
0815-9319 1440-1746 |
language |
English |
mega_collection |
Wiley (CrossRef) |
match_str |
kondo2014similaritiesanddifferencesintheclinicalfeaturesbetweencardiavaricesandesophagealvarices |
publishDateSort |
2014 |
publisher |
Wiley |
recordtype |
ai |
record_format |
ai |
series |
Journal of Gastroenterology and Hepatology |
source_id |
49 |
title |
Similarities and differences in the clinical features between cardia varices and esophageal varices |
title_unstemmed |
Similarities and differences in the clinical features between cardia varices and esophageal varices |
title_full |
Similarities and differences in the clinical features between cardia varices and esophageal varices |
title_fullStr |
Similarities and differences in the clinical features between cardia varices and esophageal varices |
title_full_unstemmed |
Similarities and differences in the clinical features between cardia varices and esophageal varices |
title_short |
Similarities and differences in the clinical features between cardia varices and esophageal varices |
title_sort |
similarities and differences in the clinical features between cardia varices and esophageal varices |
topic |
Gastroenterology Hepatology |
url |
http://dx.doi.org/10.1111/jgh.12647 |
publishDate |
2014 |
physical |
1911-1918 |
description |
<jats:title>Abstract</jats:title><jats:sec><jats:title>Background and Aim</jats:title><jats:p>Little is known about the clinical features of cardia varices (<jats:styled-content style="fixed-case">CV</jats:styled-content>). The aim was to examine the background, bleeding risk, and post‐treatment outcomes of <jats:styled-content style="fixed-case">CV</jats:styled-content> in patients with portal hypertension.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>The subjects of this retrospective study were 277 patients (179 males, 98 females, 62.9 ± 11.5 years) with esophageal varices (<jats:styled-content style="fixed-case">EV</jats:styled-content>). In patients with CV, there were 65 bleeders, and 95 patients received endoscopic treatment for primary or secondary prophylaxis.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>There were 147 patients with <jats:styled-content style="fixed-case">CV</jats:styled-content> (53.1%). The higher grade of <jats:styled-content style="fixed-case">EV</jats:styled-content> (<jats:italic>P</jats:italic> < 0.01) and the lower grade of gastric fundal varices (<jats:styled-content style="fixed-case">FV</jats:styled-content>) (<jats:italic>P</jats:italic> = 0.046) were significant factors for the presence of <jats:styled-content style="fixed-case">CV</jats:styled-content>. Significant risk factors for bleeding were: the higher grade of <jats:styled-content style="fixed-case">EV</jats:styled-content> (<jats:italic>P</jats:italic> < 0.01), red sign on <jats:styled-content style="fixed-case">EV</jats:styled-content> (<jats:italic>P</jats:italic> < 0.01), lower albumin (<jats:italic>P</jats:italic> = 0.01), and <jats:styled-content style="fixed-case">C</jats:styled-content>hild‐<jats:styled-content style="fixed-case">P</jats:styled-content>ugh B/C (<jats:italic>P</jats:italic> < 0.01) for <jats:styled-content style="fixed-case">EV</jats:styled-content> and red sign on <jats:styled-content style="fixed-case">CV</jats:styled-content> (<jats:italic>P</jats:italic> < 0.01) and use of non‐steroidal anti‐inflammatory drugs (<jats:styled-content style="fixed-case">NSAID</jats:styled-content>s)/aspirin (<jats:italic>P</jats:italic> < 0.01) for <jats:styled-content style="fixed-case">CV</jats:styled-content>. All <jats:styled-content style="fixed-case">CV</jats:styled-content> disappeared by sclerotherapy combined with argon plasma coagulation or band ligation, and 20 patients (21.1%) in EV and 18 patients (18.9%) in CV had recurrences during the median observation period of 19.4 months. There was no significant difference in the cumulative survival rate between non‐bleeders, bleeders from <jats:styled-content style="fixed-case">EV</jats:styled-content>, and those from <jats:styled-content style="fixed-case">CV</jats:styled-content>.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>The <jats:styled-content style="fixed-case">CV</jats:styled-content> were closely associated with advanced grade of <jats:styled-content style="fixed-case">EV</jats:styled-content> and less‐advanced grade of <jats:styled-content style="fixed-case">FV</jats:styled-content>. Further, usage of <jats:styled-content style="fixed-case">NSAIDs</jats:styled-content>/aspirin and red sign were significantly related to the bleeding from <jats:styled-content style="fixed-case">CV</jats:styled-content>, suggesting the need for careful management.</jats:p></jats:sec> |
container_issue |
11 |
container_start_page |
1911 |
container_title |
Journal of Gastroenterology and Hepatology |
container_volume |
29 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792334811233255434 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T14:34:35.425Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Similarities+and+differences+in+the+clinical+features+between+cardia+varices+and+esophageal+varices&rft.date=2014-11-01&genre=article&issn=1440-1746&volume=29&issue=11&spage=1911&epage=1918&pages=1911-1918&jtitle=Journal+of+Gastroenterology+and+Hepatology&atitle=Similarities+and+differences+in+the+clinical+features+between+cardia+varices+and+esophageal+varices&aulast=Yokosuka&aufirst=Osamu&rft_id=info%3Adoi%2F10.1111%2Fjgh.12647&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792334811233255434 |
author | Kondo, Takayuki, Maruyama, Hitoshi, Kiyono, Soichiro, Sekimoto, Tadashi, Shimada, Taro, Takahashi, Masanori, Okugawa, Hidehiro, Kobayashi, Satoshi, Yoshizumi, Hiroaki, Yokosuka, Osamu |
author_facet | Kondo, Takayuki, Maruyama, Hitoshi, Kiyono, Soichiro, Sekimoto, Tadashi, Shimada, Taro, Takahashi, Masanori, Okugawa, Hidehiro, Kobayashi, Satoshi, Yoshizumi, Hiroaki, Yokosuka, Osamu, Kondo, Takayuki, Maruyama, Hitoshi, Kiyono, Soichiro, Sekimoto, Tadashi, Shimada, Taro, Takahashi, Masanori, Okugawa, Hidehiro, Kobayashi, Satoshi, Yoshizumi, Hiroaki, Yokosuka, Osamu |
author_sort | kondo, takayuki |
container_issue | 11 |
container_start_page | 1911 |
container_title | Journal of Gastroenterology and Hepatology |
container_volume | 29 |
description | <jats:title>Abstract</jats:title><jats:sec><jats:title>Background and Aim</jats:title><jats:p>Little is known about the clinical features of cardia varices (<jats:styled-content style="fixed-case">CV</jats:styled-content>). The aim was to examine the background, bleeding risk, and post‐treatment outcomes of <jats:styled-content style="fixed-case">CV</jats:styled-content> in patients with portal hypertension.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>The subjects of this retrospective study were 277 patients (179 males, 98 females, 62.9 ± 11.5 years) with esophageal varices (<jats:styled-content style="fixed-case">EV</jats:styled-content>). In patients with CV, there were 65 bleeders, and 95 patients received endoscopic treatment for primary or secondary prophylaxis.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>There were 147 patients with <jats:styled-content style="fixed-case">CV</jats:styled-content> (53.1%). The higher grade of <jats:styled-content style="fixed-case">EV</jats:styled-content> (<jats:italic>P</jats:italic> < 0.01) and the lower grade of gastric fundal varices (<jats:styled-content style="fixed-case">FV</jats:styled-content>) (<jats:italic>P</jats:italic> = 0.046) were significant factors for the presence of <jats:styled-content style="fixed-case">CV</jats:styled-content>. Significant risk factors for bleeding were: the higher grade of <jats:styled-content style="fixed-case">EV</jats:styled-content> (<jats:italic>P</jats:italic> < 0.01), red sign on <jats:styled-content style="fixed-case">EV</jats:styled-content> (<jats:italic>P</jats:italic> < 0.01), lower albumin (<jats:italic>P</jats:italic> = 0.01), and <jats:styled-content style="fixed-case">C</jats:styled-content>hild‐<jats:styled-content style="fixed-case">P</jats:styled-content>ugh B/C (<jats:italic>P</jats:italic> < 0.01) for <jats:styled-content style="fixed-case">EV</jats:styled-content> and red sign on <jats:styled-content style="fixed-case">CV</jats:styled-content> (<jats:italic>P</jats:italic> < 0.01) and use of non‐steroidal anti‐inflammatory drugs (<jats:styled-content style="fixed-case">NSAID</jats:styled-content>s)/aspirin (<jats:italic>P</jats:italic> < 0.01) for <jats:styled-content style="fixed-case">CV</jats:styled-content>. All <jats:styled-content style="fixed-case">CV</jats:styled-content> disappeared by sclerotherapy combined with argon plasma coagulation or band ligation, and 20 patients (21.1%) in EV and 18 patients (18.9%) in CV had recurrences during the median observation period of 19.4 months. There was no significant difference in the cumulative survival rate between non‐bleeders, bleeders from <jats:styled-content style="fixed-case">EV</jats:styled-content>, and those from <jats:styled-content style="fixed-case">CV</jats:styled-content>.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>The <jats:styled-content style="fixed-case">CV</jats:styled-content> were closely associated with advanced grade of <jats:styled-content style="fixed-case">EV</jats:styled-content> and less‐advanced grade of <jats:styled-content style="fixed-case">FV</jats:styled-content>. Further, usage of <jats:styled-content style="fixed-case">NSAIDs</jats:styled-content>/aspirin and red sign were significantly related to the bleeding from <jats:styled-content style="fixed-case">CV</jats:styled-content>, suggesting the need for careful management.</jats:p></jats:sec> |
doi_str_mv | 10.1111/jgh.12647 |
facet_avail | Online |
finc_class_facet | Medizin |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qZ2guMTI2NDc |
imprint | Wiley, 2014 |
imprint_str_mv | Wiley, 2014 |
institution | DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Gla1, DE-Zi4, DE-15 |
issn | 0815-9319, 1440-1746 |
issn_str_mv | 0815-9319, 1440-1746 |
language | English |
last_indexed | 2024-03-01T14:34:35.425Z |
match_str | kondo2014similaritiesanddifferencesintheclinicalfeaturesbetweencardiavaricesandesophagealvarices |
mega_collection | Wiley (CrossRef) |
physical | 1911-1918 |
publishDate | 2014 |
publishDateSort | 2014 |
publisher | Wiley |
record_format | ai |
recordtype | ai |
series | Journal of Gastroenterology and Hepatology |
source_id | 49 |
spelling | Kondo, Takayuki Maruyama, Hitoshi Kiyono, Soichiro Sekimoto, Tadashi Shimada, Taro Takahashi, Masanori Okugawa, Hidehiro Kobayashi, Satoshi Yoshizumi, Hiroaki Yokosuka, Osamu 0815-9319 1440-1746 Wiley Gastroenterology Hepatology http://dx.doi.org/10.1111/jgh.12647 <jats:title>Abstract</jats:title><jats:sec><jats:title>Background and Aim</jats:title><jats:p>Little is known about the clinical features of cardia varices (<jats:styled-content style="fixed-case">CV</jats:styled-content>). The aim was to examine the background, bleeding risk, and post‐treatment outcomes of <jats:styled-content style="fixed-case">CV</jats:styled-content> in patients with portal hypertension.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>The subjects of this retrospective study were 277 patients (179 males, 98 females, 62.9 ± 11.5 years) with esophageal varices (<jats:styled-content style="fixed-case">EV</jats:styled-content>). In patients with CV, there were 65 bleeders, and 95 patients received endoscopic treatment for primary or secondary prophylaxis.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>There were 147 patients with <jats:styled-content style="fixed-case">CV</jats:styled-content> (53.1%). The higher grade of <jats:styled-content style="fixed-case">EV</jats:styled-content> (<jats:italic>P</jats:italic> < 0.01) and the lower grade of gastric fundal varices (<jats:styled-content style="fixed-case">FV</jats:styled-content>) (<jats:italic>P</jats:italic> = 0.046) were significant factors for the presence of <jats:styled-content style="fixed-case">CV</jats:styled-content>. Significant risk factors for bleeding were: the higher grade of <jats:styled-content style="fixed-case">EV</jats:styled-content> (<jats:italic>P</jats:italic> < 0.01), red sign on <jats:styled-content style="fixed-case">EV</jats:styled-content> (<jats:italic>P</jats:italic> < 0.01), lower albumin (<jats:italic>P</jats:italic> = 0.01), and <jats:styled-content style="fixed-case">C</jats:styled-content>hild‐<jats:styled-content style="fixed-case">P</jats:styled-content>ugh B/C (<jats:italic>P</jats:italic> < 0.01) for <jats:styled-content style="fixed-case">EV</jats:styled-content> and red sign on <jats:styled-content style="fixed-case">CV</jats:styled-content> (<jats:italic>P</jats:italic> < 0.01) and use of non‐steroidal anti‐inflammatory drugs (<jats:styled-content style="fixed-case">NSAID</jats:styled-content>s)/aspirin (<jats:italic>P</jats:italic> < 0.01) for <jats:styled-content style="fixed-case">CV</jats:styled-content>. All <jats:styled-content style="fixed-case">CV</jats:styled-content> disappeared by sclerotherapy combined with argon plasma coagulation or band ligation, and 20 patients (21.1%) in EV and 18 patients (18.9%) in CV had recurrences during the median observation period of 19.4 months. There was no significant difference in the cumulative survival rate between non‐bleeders, bleeders from <jats:styled-content style="fixed-case">EV</jats:styled-content>, and those from <jats:styled-content style="fixed-case">CV</jats:styled-content>.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>The <jats:styled-content style="fixed-case">CV</jats:styled-content> were closely associated with advanced grade of <jats:styled-content style="fixed-case">EV</jats:styled-content> and less‐advanced grade of <jats:styled-content style="fixed-case">FV</jats:styled-content>. Further, usage of <jats:styled-content style="fixed-case">NSAIDs</jats:styled-content>/aspirin and red sign were significantly related to the bleeding from <jats:styled-content style="fixed-case">CV</jats:styled-content>, suggesting the need for careful management.</jats:p></jats:sec> Similarities and differences in the clinical features between cardia varices and esophageal varices Journal of Gastroenterology and Hepatology |
spellingShingle | Kondo, Takayuki, Maruyama, Hitoshi, Kiyono, Soichiro, Sekimoto, Tadashi, Shimada, Taro, Takahashi, Masanori, Okugawa, Hidehiro, Kobayashi, Satoshi, Yoshizumi, Hiroaki, Yokosuka, Osamu, Journal of Gastroenterology and Hepatology, Similarities and differences in the clinical features between cardia varices and esophageal varices, Gastroenterology, Hepatology |
title | Similarities and differences in the clinical features between cardia varices and esophageal varices |
title_full | Similarities and differences in the clinical features between cardia varices and esophageal varices |
title_fullStr | Similarities and differences in the clinical features between cardia varices and esophageal varices |
title_full_unstemmed | Similarities and differences in the clinical features between cardia varices and esophageal varices |
title_short | Similarities and differences in the clinical features between cardia varices and esophageal varices |
title_sort | similarities and differences in the clinical features between cardia varices and esophageal varices |
title_unstemmed | Similarities and differences in the clinical features between cardia varices and esophageal varices |
topic | Gastroenterology, Hepatology |
url | http://dx.doi.org/10.1111/jgh.12647 |